ARCT - Arcturus Therapeutics Holdings Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
25,503
15,753
12,998
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
23,409
16,982
15,918
18,391
13,461
Selling General and Administrative
14,241
20,582
7,572
5,357
4,992
Total Operating Expenses
37,650
37,564
23,490
25,167
19,698
Operating Income or Loss
-12,147
-21,811
-10,492
-25,167
-19,698
Interest Expense
-
186
150
142
31
Total Other Income/Expenses Net
-543
-302
-348
-1,419
-1,245
Income Before Tax
-12,833
-21,785
-10,901
-24,530
-19,398
Income Tax Expense
-
0
1
73
51
Income from Continuing Operations
-12,833
-21,785
-10,902
-24,603
-19,449
Net Income
-12,833
-21,785
-10,902
-24,603
-19,449
Net Income available to common shareholders
-12,833
-21,785
-10,902
-24,603
-19,449
Reported EPS
Basic
-
-2.16
-3.53
-6.23
-6.30
Diluted
-
-2.16
-3.53
-6.23
-6.30
Weighted average shares outstanding
Basic
-
10,069
3,087
3,938
3,091
Diluted
-
10,069
3,087
3,938
3,091
EBITDA
-
-21,017
-10,341
-24,327
-19,647